Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001338895 | SCV001532600 | uncertain significance | not provided | 2024-01-15 | criteria provided, single submitter | clinical testing | This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 320 of the LMX1B protein (p.Val320Met). This variant is present in population databases (rs778847250, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with LMX1B-related conditions. ClinVar contains an entry for this variant (Variation ID: 1035953). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt LMX1B protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Baylor Genetics | RCV003333157 | SCV004040861 | uncertain significance | Nail-patella-like renal disease | 2023-02-01 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003333156 | SCV004041037 | uncertain significance | Nail-patella syndrome | 2023-02-01 | criteria provided, single submitter | clinical testing |